Europe looks increasingly likely to follow America’s lead and require drug companies to test their products in children. But Europe's pharma lack the resources to carry out drug trials in children — so industry and patients will have to rely on the skills developed in academic centres.
By mixing academic research with commercial ventures, Sir Richard Friend has returned to the scientific traditions of Faraday and Kelvin. He has also created a new role model for the modern scientist.
Not everyone can produce a Google, Stanford's way of doing business is making other universities look with interest at the revenue possibilities of equity deals.
Once upon a time, there were great businesses with massive central labs that did both product development and basic research. Today, most corporate labs have refocused on applied research. They do not know what they are missing.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.